Segra International Awarded Cannabis Analytical Testing License

Segra International Corp., an agriculture technology company, announced the approval of its Analytical Testing License from Health Canada under the Cannabis Act and Cannabis Regulations.

Segra’s Molecular Lab opened in 2017 to provide pathogen diagnostic testing and cultivar identification services for the company’s tissue culture facility. These services have become a critical part of the quality assurance process that underlays its Verified Clean Stock program, and now includes ten Real Time PCR-based plant pathogen assays, including for HLVd. Having in-house molecular testing services is an important differentiator for Segra and provides its customers with peace of mind that they receive heathy, true to type, disease-free plantlets. After performing nearly 10,000 assays in the 2021-2022 fiscal year, the company has upgraded its lab to increase capacity and now offer these services to its customers and other third parties looking for better crop surveillance tools.

"We have been using Segra's molecular lab for internal purposes and after feedback from customers, it’s time to make these value-added services available for all LPs in an effort to help mitigate cultivation risks, increase supply chain security and to monitor your fungal pathogen, virus and viroid load, all standard best practices in other commercially grown crops." stated Jamie Blundell, CEO of Segra.

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Photo: Benzinga edit with photos by jarmoluk and lindsayfox on Pixabay